Stock data

泰博 (4736)

泰博 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$398.41M, up 7.1% from a year earlier. EPS over the last four quarters totals NT$26.98.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 泰博 in Insightr